Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Study of Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections （ZSNeo-DC ）for Malignant Solid Tumors

NCT07752953 is registered in ClinicalTrials.gov with ZSky Biotech Inc as lead sponsor.

NCT NCT07752953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07752953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Study of Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections （ZSNeo-DC ）for Malignant Solid Tumors
Lead sponsor
ZSky Biotech Inc
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2026
Completion date
August 10, 2030
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, cancer, malignant solid tumor